Market revenue in 2023 | USD 615.0 million |
Market revenue in 2030 | USD 864.6 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 32.1% in 2023. Horizon Databook has segmented the Canada oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Canada held 5.4% of the market share in 2023. The country supports its pharmaceutical requirement through outsourcing firms that cater to manufacturing, thereby leading to increasing outsourcing activity in the region.
pharmaceutical production and have a positive impact on the market. Furthermore, increasing manufacturing of solid dosages in all shapes & sizes, requirement for improving operator safety, quality & reliability.
As well as reducing costs, and R&D conducted in the country externally & through partnerships are among the high impact rendering factors driving market growth in this country. In addition, the growing burden of different diseases creates significant demand for oral solid dosage.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Canada oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account